AnalystsBrandon CouillardBrandon Couillard's Stock Forecasts
AnalystsBrandon Couillard
Analyst Ranking
Top 17%
#637 out of 3861 analysts
Average Return
+15.45%
Win Rate
60%9 out of 15
Risk vs Reward
Poor
Good
Brandon Couillard's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Codexis IncCDXS | +275.00% | $4.00 | $15.00 | 2017-05-30 - 2018-05-31 | Strong Buy |
Exact Sciences CorpEXAS | +122.87% | $51.63 | $115.07 | 2018-08-01 - 2019-08-02 | Strong Buy |
Codexis IncCDXS | +104.40% | $7.50 | $15.33 | 2017-10-12 - 2018-10-12 | Strong Buy |
Align Technology IncALGN | +32.27% | $453.23 | $599.49 | 2020-10-21 - 2021-10-21 | Strong Buy |
Quotient LtdQTNT | +26.84% | $5.03 | $6.38 | 2017-10-31 - 2018-11-01 | Strong Buy |
Brandon Couillard's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sema4 Holdings CorpSMFR | 2 | Hold | $2.00 | +25.00% | Downgrades | 2 days ago |
Somalogic IncSLGC | 1 | Strong Buy | $16.00 | +276.47% | Initiates Coverage On | 8 months ago |
Agilent Technologies IncA | 2 | Strong Buy | $185.00 | +39.34% | Maintains | a year ago |
Codex Dna IncDNAY | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Nautilus Biotechnology IncNAUT | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | a year ago |
Bio Rad Laboratories IncBIO | 2 | Strong Buy | $725.00 | N/A | Maintains | 2 years ago |
Align Technology IncALGN | 1 | Strong Buy | $450.00 | N/A | Maintains | 2 years ago |
Smiledirectclub IncSDC | 1 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Quotient LtdQTNT | 2 | Strong Buy | $13.50 | N/A | Maintains | 3 years ago |
Exact Sciences CorpEXAS | 2 | Strong Buy | $84.00 | N/A | Maintains | 4 years ago |
Henry Schein IncHSIC | 1 | Hold | $74.00 | N/A | Maintains | 5 years ago |
Orasure Technologies IncOSUR | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Codexis IncCDXS | 2 | Strong Buy | $11.00 | N/A | Maintains | 5 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.